Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.
- Chamber
- Senate
- Introduced
- Apr 28, 2025
- Last action
- Jan 7, 2026 — REFERRED TO CONSUMER PROTECTION
- Session
- 2025-2026
- Momentum
- 41 · Moderate